Questionable utility of digoxin in left-ventricular assist device recipients: A multicenter, retrospective analysis.

In this large, multicenter cohort, use of digoxin was not associated with any significant benefit in regard to mortality or hospitalization in patients supported with a continuous-flow LVAD. Importantly, its discontinuation post implant did not worsen all-cause hospitalization or survival.